文献速递运动医学关节外科

延迟手术与腺苷、利多卡因及镁离子免疫调节治疗以性别特异性方式改善大鼠前交叉韧带重建术后关节恢复

Delayed Surgery and Adenosine, Lidocaine, and Mg2+ Immunomodulatory Therapy Improve Joint Recovery in a Sex-Specific Manner After Anterior Cruciate Ligament Reconstruction in a Rat Model.
PubMed 文献 · Am J Sports Med · 2025-10-23

研究在大鼠前交叉韧带断裂模型中比较早期(延迟3天)与延迟(延迟14天)重建手术及围术期腺苷、利多卡因和镁离子(ALM)治疗对术后恢复的影响。结果显示延迟重建与较少的全身炎症、更快的体重恢复和更轻的关节疼痛肿胀相关,ALM可减轻滑膜炎症介质并改善移植物愈合,雌性移植物及邻近关节组织愈合似乎优于雄性。

要点

  • 延迟前交叉韧带重建与较少的全身炎症及更快的体重恢复、更轻的关节疼痛肿胀相关。
  • ALM治疗降低滑膜肿瘤坏死因子-α和白细胞介素-1β水平并改善移植物愈合。
  • 术后28天雌性移植物及邻近关节组织愈合似乎比雄性更先进,与手术时机无关。

核心结论

  • 延迟与早期前交叉韧带重建相比改善关节恢复,ALM通过减轻早期免疫炎症反应进一步增强愈合,在两性中均如此且与手术时机无关。

研究设计与样本

  • 对照实验室研究:成年雄性(n=38)和雌性(n=39)Sprague-Dawley大鼠在非侵入性前交叉韧带断裂后随机分为早期(延迟3天)或延迟(延迟14天)重建手术组,并接受ALM或生理盐水治疗。

主要发现

  • 术后第一周,延迟重建与淋巴细胞驱动的免疫反应相关,全身炎症较早期重建少,两性中均与更快的体重恢复和更轻的关节疼痛肿胀相关。
  • 术后28天,无论手术时机如何,雌性移植物及邻近关节组织愈合似乎比雄性更先进。
  • 两性中ALM均减弱滑膜炎症介质(肿瘤坏死因子-α和白细胞介素-1β)水平、减少关节软骨损伤标志物并改善移植物愈合,表现为组织修复标志物表达增加和移植物-隧道界面骨长入。

临床怎么用

  • 作者指出延迟前交叉韧带重建具有减少术前和术后关节炎症环境的优势并改善结局。
  • 作者认为围术期ALM治疗可能增强两性前交叉韧带重建术后的关节愈合。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The timing for anterior cruciate ligament (ACL) reconstruction (ACLR) and strategies to enhance postoperative healing remain controversial, with little known regarding potential sex-specific differences. Perioperative adenosine, lidocaine, and Mg2+ (ALM) therapy has been shown to promote joint tissue healing in an experimental model of early ACLR; however, an early-late comparison of ALM's effects on postoperative recovery remains to be investigated. PURPOSE: To examine the effect of delayed surgery in males and females, and the effect of ALM therapy to augment joint tissue healing. STUDY DESIGN: Controlled laboratory study. METHODS: After noninvasive ACL rupture, adult male (n = 38) and female (n = 39) Sprague-Dawley rats were randomly divided into early (3-day delay) or delayed (14-day delay) ACLR surgery groups, and to receive ALM therapy or saline. During ACLR, an ALM or saline intravenous 1-hour infusion was commenced before first incision, and an intra-articular bolus of ALM or saline was administered at surgery end. Animals were monitored to 28 days postoperatively, and pain, functional recovery, inflammation and joint tissue repair markers, and histopathology were assessed. RESULTS: In the first postoperative week, delayed ACLR was associated with a lymphocyte-driven immune response, with less systemic inflammation compared with early ACLR. This response was associated with faster recovery of body weight, and less joint pain and swelling in both sexes. At 28 days postoperatively, graft and adjacent joint tissue healing appeared more advanced in females than males, regardless of surgical timing. In both sexes, ALM blunted synovial levels of inflammatory mediators (tumor necrosis factor-α and interleukin-1β), reduced injury markers in articular cartilage, and improved graft healing, evidenced from increased expression of tissue repair markers and bony ingrowth at the graft-tunnel interface. CONCLUSION: Delayed versus early ACLR improves joint recovery, and ALM further augments healing by blunting the early immunoinflammatory response in both sexes, irrespective of surgical timing. CLINICAL RELEVANCE: Delaying ACLR has the advantage of reducing the pre- and postoperative joint inflammatory environment, with improved outcomes. Perioperative ALM therapy may augment joint healing in both sexes after ACLR.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Morris JL, Letson HL, McEwen PC, et al. Delayed Surgery and Adenosine, Lidocaine, and Mg2+ Immunomodulatory Therapy Improve Joint Recovery in a Sex-Specific Manner After Anterior Cruciate Ligament Reconstruction in a Rat Model. Am J Sports Med. 2025. PMID: 41128403. doi:10.1177/03635465251383556

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。